US NAT yield: where are we after 2 years? (Q34830197)

4 August 2017

1 reference

title

US NAT yield: where are we after 2 years? (English)

1 reference

4 August 2017

Stramer SL

1

1 reference

4 August 2017

publication date

1 August 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

12

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

243-253

1 reference

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-3148.2002.00387.X

Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-3148.2002.00387.X

False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-3148.2002.00387.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-3148.2002.00387.X

Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-3148.2002.00387.X

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-3148.2002.00387.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-3148.2002.00387.X

Why is there such difficulty in defining the natural history of hepatitis C?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-3148.2002.00387.X

NAT of the United States and Canadian blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-3148.2002.00387.X

Hepatitis C genotypes: current trends and future implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-3148.2002.00387.X

10.1046/J.1365-3148.2002.00387.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference